| Product Code: ETC6751778 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Prophylactic Vaccines Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 China Prophylactic Vaccines Market - Industry Life Cycle |
3.4 China Prophylactic Vaccines Market - Porter's Five Forces |
3.5 China Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 China Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 China Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 China Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 China Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 China Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government focus on immunization programs |
4.2.2 Growing awareness about preventive healthcare measures |
4.2.3 Rising prevalence of infectious diseases in China |
4.3 Market Restraints |
4.3.1 Stringent regulations for vaccine approvals and distribution |
4.3.2 Vaccine hesitancy among certain population segments |
5 China Prophylactic Vaccines Market Trends |
6 China Prophylactic Vaccines Market, By Types |
6.1 China Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 China Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 China Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 China Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 China Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 China Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 China Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 China Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 China Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 China Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 China Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 China Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 China Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 China Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 China Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 China Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 China Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 China Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 China Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 China Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 China Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 China Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 China Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 China Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 China Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 China Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 China Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 China Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 China Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 China Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 China Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 China Prophylactic Vaccines Market Export to Major Countries |
7.2 China Prophylactic Vaccines Market Imports from Major Countries |
8 China Prophylactic Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rates in key demographic groups |
8.2 Investments in research and development for new vaccines |
8.3 Public perception and trust in vaccine efficacy |
8.4 Number of reported cases of vaccine-preventable diseases |
8.5 Adoption rates of new vaccination technologies and delivery methods |
9 China Prophylactic Vaccines Market - Opportunity Assessment |
9.1 China Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 China Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 China Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 China Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 China Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 China Prophylactic Vaccines Market - Competitive Landscape |
10.1 China Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 China Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here